179 related articles for article (PubMed ID: 38420833)
21. Clinical utility and real-world application of molecular genetic sequencing in the management of patients with acute myeloid leukemia and myelodysplastic syndromes.
Banaszak LG; Reinig E; Lasarev MR; Mattison RJ
Leuk Lymphoma; 2022 Mar; 63(3):684-693. PubMed ID: 34865601
[TBL] [Abstract][Full Text] [Related]
22. Wilms' tumor 1 gene in hematopoietic malignancies: clinical implications and future directions.
Luo P; Jing W; Yi K; Wu S; Zhou F
Leuk Lymphoma; 2020 Sep; 61(9):2059-2067. PubMed ID: 32401109
[TBL] [Abstract][Full Text] [Related]
23. The changing mutational landscape of acute myeloid leukemia and myelodysplastic syndrome.
Larsson CA; Cote G; Quintás-Cardama A
Mol Cancer Res; 2013 Aug; 11(8):815-27. PubMed ID: 23645565
[TBL] [Abstract][Full Text] [Related]
24. Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell Transplantation.
Rautenberg C; Pechtel S; Hildebrandt B; Betz B; Dienst A; Nachtkamp K; Kondakci M; Geyh S; Wieczorek D; Haas R; Germing U; Kobbe G; Schroeder T
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2337-2343. PubMed ID: 29753838
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia.
Falini B; Martelli MP
Am J Hematol; 2023 Mar; 98(3):481-492. PubMed ID: 36606297
[TBL] [Abstract][Full Text] [Related]
26. Clonal evolution and hierarchy in myeloid malignancies.
Takahashi K; Tanaka T
Trends Cancer; 2023 Sep; 9(9):707-715. PubMed ID: 37302922
[TBL] [Abstract][Full Text] [Related]
27. [Next-generation sequencing and its application in acute myeloid leukemia and myelodysplastic syndrome].
Gu SC; Chang CK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1545-9. PubMed ID: 22169322
[TBL] [Abstract][Full Text] [Related]
28. Molecular findings in myeloid neoplasms.
Tran TB; Siddon AJ
Int J Lab Hematol; 2023 Aug; 45(4):442-448. PubMed ID: 37345257
[TBL] [Abstract][Full Text] [Related]
29. Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations.
West AH; Godley LA; Churpek JE
Ann N Y Acad Sci; 2014 Mar; 1310(1):111-8. PubMed ID: 24467820
[TBL] [Abstract][Full Text] [Related]
30. Dynamic Treatment Stratification Using ctDNA.
Vidal J; Taus A; Montagut C
Recent Results Cancer Res; 2020; 215():263-273. PubMed ID: 31605234
[TBL] [Abstract][Full Text] [Related]
31. Special Issue "Advances in Molecular Pathogenesis and Targeted Therapies for Myeloid Neoplasms".
Kok CH; Yeung DT; Hiwase DK
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396733
[TBL] [Abstract][Full Text] [Related]
32. Challenges facing minimal residual disease testing for acute myeloid leukemia and promising strategies to overcome them.
Li SQ; Chen M; Huang XY; Wang H; Chang YJ
Expert Rev Hematol; 2023; 16(12):981-990. PubMed ID: 37978882
[TBL] [Abstract][Full Text] [Related]
33. Molecular Minimal Residual Disease Monitoring in Acute Myeloid Leukemia: Challenges and Future Directions.
Selim AG; Moore AS
J Mol Diagn; 2018 Jul; 20(4):389-397. PubMed ID: 29689379
[TBL] [Abstract][Full Text] [Related]
34. Modulating the immune system as a therapeutic target for myelodysplastic syndromes and acute myeloid leukemia.
Putnam C; Kondeti L; Kesler M; Varney M
Biochem Cell Biol; 2023 Dec; 101(6):481-495. PubMed ID: 37566901
[TBL] [Abstract][Full Text] [Related]
35. Advances in Diagnosis and Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Pillai RK; Afkhami M
Cancer Treat Res; 2021; 181():1-16. PubMed ID: 34626352
[TBL] [Abstract][Full Text] [Related]
36. Cytogenetics and molecular genetics of myelodysplastic neoplasms.
Ning Y; Zhang Y; Kallen MA; Emadi A; Baer MR
Best Pract Res Clin Haematol; 2023 Dec; 36(4):101512. PubMed ID: 38092472
[TBL] [Abstract][Full Text] [Related]
37. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.
Ronaghy A; Yang RK; Khoury JD; Kanagal-Shamanna R
Curr Hematol Malig Rep; 2020 Jun; 15(3):194-202. PubMed ID: 32382988
[TBL] [Abstract][Full Text] [Related]
38. The Problem of TP53-Mutant MDS/AML.
Sallman DA
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20 Suppl 1():S65-S66. PubMed ID: 32862873
[No Abstract] [Full Text] [Related]
39. Prognostic impact of circulating tumor DNA status post-allogeneic hematopoietic stem cell transplantation in AML and MDS.
Nakamura S; Yokoyama K; Shimizu E; Yusa N; Kondoh K; Ogawa M; Takei T; Kobayashi A; Ito M; Isobe M; Konuma T; Kato S; Kasajima R; Wada Y; Nagamura-Inoue T; Yamaguchi R; Takahashi S; Imoto S; Miyano S; Tojo A
Blood; 2019 Jun; 133(25):2682-2695. PubMed ID: 30936070
[TBL] [Abstract][Full Text] [Related]
40. Novel Tools for Diagnosis and Monitoring of AML.
Guijarro F; Garrote M; Villamor N; Colomer D; Esteve J; López-Guerra M
Curr Oncol; 2023 May; 30(6):5201-5213. PubMed ID: 37366878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
